5. Smith+Nephew to buy Integra extremities business for $240M
Smith+Nephew in September announced an agreement to spend $240 million to acquire the extremity orthopedics business from Integra LifeSciences. As of the time of writing in late December, the deal was expected to close around the end of the year. S+N officials say the acquisition will significantly strengthen the company’s extremities business by adding a combination of a focused sales channel and complimentary shoulder replacement and upper and lower extremities portfolios, plus a new product pipeline.
